Literature DB >> 11448424

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial.

R J Lederman1, A N Tenaglia, R D Anderson, J B Hermiller, K Rocha-Singh, F O Mendelsohn, W R Hiatt, T Moon, M J Whitehouse, B H Annex.   

Abstract

The Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 for Intermittent Claudication (TRAFFIC) is a large, randomized, placebo-controlled, regimen-finding trial of intra-arterial recombinant fibroblast growth factor-2 in patients with intermittent claudication. This report describes the major design considerations and end points in TRAFFIC.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11448424     DOI： 10.1016/s0002-9149(01)01622-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

1.  Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.

Authors:  Anthony J Monteforte; Brian Lam; Subhamoy Das; Somshuvra Mukhopadhyay; Catherine S Wright; Patricia E Martin; Andrew K Dunn; Aaron B Baker
Journal:  Biomaterials       Date:  2016-04-11       Impact factor: 12.479

Review 2.  Growth factors for angiogenesis in peripheral arterial disease.

Authors:  Vitali Gorenoi; Michael U Brehm; Armin Koch; Anja Hagen
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

3.  Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2).

Authors:  Ronnier J Aviles; Brian H Annex; Robert J Lederman
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

4.  Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system.

Authors:  Subhamoy Das; Gunjan Singh; Aaron B Baker
Journal:  Biomaterials       Date:  2013-10-16       Impact factor: 12.479

Review 5.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.